DYRK2 and triple-negative breast carcinoma: Additionally, it has been demonstrated that DYRK2 suppression by knockout or inhibition with curcumin or LDN192960 leads to an increase of apoptosis in triple-negative breast cancer cells and xenografts due to a reduction of the 26S proteasome activity [13, 14].